Direct Comparisons Of Three Alternative Plasma Fibrinogen Assays With The Von Clauss Assay In Prediction Of Cardiovascular Disease And All-Causes Mortality: The Scottish Heart Health Extended Cohort

British Journal of Haematology

Volumn 162, Issue 3, 2013, Pages 392-399

  Peters, Sanne A E ^a,b   Woodward, Mark ^a,c,d   Rumley, Ann ^c   Koenig, Wolfgang ^e   Tunstall Pedoe, Hugh ^d   Lowe, Gordon D O ^c  

^a Epidemiology Health Reform Transitional Office Western   (Australia)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e UNIVERSITY OF ULM   (Germany)

Author keywords

Assays; Cardiovascular disease; Epidemiology; Fibrinogen; Mortality

Indexed keywords

FIBRINOGEN;

ADULT; ARTICLE; ASSAY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HAZARD RATIO; HEAT PRECIPITATION ASSAY; HUMAN; IMMUNONEPHELOMETRIC ASSAY; INTERMETHOD COMPARISON; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; PROTHROMBIN TIME DERIVED ASSAY; RISK ASSESSMENT; UNITED KINGDOM; VON CLAUSS ASSAY;

ASSAYS; CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; FIBRINOGEN; MORTALITY;

ADULT; BIOLOGICAL MARKERS; BLOOD COAGULATION TESTS; CARDIOVASCULAR DISEASES; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; MORTALITY; NEPHELOMETRY AND TURBIDIMETRY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTHROMBIN TIME; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SCOTLAND;

EID: 84880290086     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12389     Document Type: Article

References (22)

1. Cremer, P., Nagel, D., Labrot, B., Mann, H., Muche, R., Elster, H. & Seidel, C. (1994) Lipoprotein (Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Gottingen Risk Incidence and Prevalence Study (GRIPS). European Journal of Clinical Investigation, 24, 444-453.
2. Danesh, J., Lewington, S., Thompson, S.G., Lowe, G.D.O. & Collins, R. for the Fibrinogen Studies Collaboration (2005) Plasma fibrinogen level and the risk of major cardiovascular diseases and non-vascular mortality: an individual participant meta-analysis. Journal of the American Medical Association, 294, 1799-1809.
3. Gaffney, P.J. & Wong, M.Y. (1992) Collaborative study of proposed international standard for plasma fibrinogen measurement. Thrombosis and Haemostasis, 68, 428-432.
4. Kaptoge, S., Di Angelantonio, E., Lowe, G., Pepys, M.B., Thompson, S.E., Collins, R. & Danesh, J. for the Emerging Risk Factors Collaboration (2010) C-reactive protein concentration and the risk of coronary heart disease, stroke and mortality. Lancet, 375, 132-140.
5. Lovely, R.S., Kazmierczak, S.C., Massaro, J.M., D'Agostino, R.B., O'Donnell, C.J. & Farrell, D.H. (2010) γ′ fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease. Clinical Chemistry, 56, 781-788.
6. Lowe, G.D.O., Woodward, M., Rumley, A., Morrison, C.E. & Nieuwenhuizen, W. (2003) Associations of plasma fibrinogen assays, C-reactive protein and interleukin-6 with previous myocardial infarction. Journal of Thrombosis and Haemostasis, 1, 2312-2316.
7. Lowe, G.D.O., Rumley, A. & Mackie, I. (2004) Analytical review: fibrinogen. Annals of Clinical Biochemistry, 41, 430-440.
8. Mackie, I.J., Kitchen, S., Machin, S. & Lowe, G.D.O. (2003) Guidelines on fibrinogen assays. British Journal of Haematology, 121, 396-404.
9. Nieuwenhuizen, W. (1995) Biochemistry and measurement of fibrinogen. European Heart Journal, 16, A6-A10.
10. Pencina, M.J. & D'Agostino, R.B. (2004) Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Statistics in Medicine, 23, 2109-2123.
11. Pencina, M.J., D'Agostino, Sr, R.B. & Steyerber, E.W. (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Statistics in Medicine, 30, 11-21.
12. Rossi, E., Mondonico, P., Lombardi, A. & Preda, L. (1988) Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers. Thrombosis Research, 52, 453-468.
13. Rumley, A., Woodward, M., Hoffmeister, A., Koenig, W. & Lowe, G.D.O. (2003) Comparison of plasma fibrinogen by Clauss, prothrombin time-derived, and immunonephelometric assays in a general population; implications for risk stratification by thirds of fibrinogen. Blood Coagulation and Fibrinolysis, 14, 197-201.
14. Sweetnam, P.M., Yarnell, J.W.G., Lowe, G.D.O., Baker, I.A., O'Brien, J.R. & Rumley, A. (1998) The relative power of heat-precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction of ischaemic heart disease; the Caerphilly and Speedwell studies. British Journal of Haematology, 100, 582-588.
15. Tunstall-Pedoe, H. (ed.) (2003) MONICA Monograph and Multimedia Sourcebook. Geneva, World Health Organization. http://whqlibdoc.who.int/publications/2003/9241562234.pdf.
16. Tunstall-Pedoe, H. & Woodward, M. for the SIGN group on risk estimation (2006) By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease. Heart, 92, 307-310.
17. Tunstall-Pedoe, H., Woodward, M., Tavendale, R., A'Brook, R. & McCluskey, M.K. (1997) Comparison of the prediction by 27 different factors for coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. British Medical Journal, 314, 541-546.
18. Von Clauss, A. (1957) Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens. Acta Haematologica, 17, 237-246.
19. Weinstock, N. & Ntefidou, M. (2006) International Collaborative Study to establish the first high fibrinogen reference material for use with different fibrinogen assay techniques. Journal of Thrombosis and Haemostasis, 4, 1825-1827.
20. Woodward, M., Lowe, G.D.O., Rumley, A. & Tunstall-Pedoe, H. (1998) Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women: the Scottish Heart Health Study. European Heart Journal, 19, 55-62.
21. Woodward, M., Brindle, P. & Tunstall-Pedoe, H. for the SIGN group on risk estimation (2007) Adding social deprivation and family history to cardiovascular risk assessment - the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart, 93, 172-176.
22. Woodward, M., Tunstall-Pedoe, H., Rumley, A. & Lowe, G.D.O. (2009) Does fibrinogen add to prediction of cardiovascular disease? Results from the Scottish Heart Health Study. British Journal of Haematology, 146, 442-446.